NEW YORK (GenomeWeb News) – Co-Diagnostics HBDC and Mentors International have inked an agreement to offer real-time PCR-based tests in developing nations at lower costs, they announced today.

Starting with a pilot program in Guatemala and an initial testing focus on tuberculosis, Co-Diagnostics HBDC will provide low-cost testing reagents, and Mentors will leverage its international network to create low-cost testing facilities. Mentors will identify machines that cost less and provide training to second-generation workers in its microfinancing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.